• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Paradigm Spine

RTI Surgical closes $300m Paradigm Spine buy

March 11, 2019 By Brad Perriello

RTI Surgical (NSDQ:RTIX) said last week that it closed the $300 million acquisition of Paradigm Spine and its Coflex lumbar stenosis device. The cash-and-stock deal, originally announced last November, called for RTI to pay $100 million in cash and more than 10.7 million shares of its own stock worth $50 million, with the $150 million balance pegged to […]

Filed Under: Featured, Mergers & Acquisitions, Orthopedics, Wall Street Beat Tagged With: Paradigm Spine, RTI Surgical

RTI Surgical shareholders approve Paradigm Spine buy

March 8, 2019 By Fink Densford

RTI Surgical (NSDQ:RTIX) said yesterday that its shareholders approved its approximately $300 million acquisition of Paradigm Spine and its Coflex lumbar stenosis device. Alachua, Fla.-based RTI Surgical said that it expects the acquisition to close today. “We are pleased RTI’s shareholders have given their strong support for our acquisition of Paradigm Spine. With shareholder approval secured, we […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Paradigm Spine, RTI Surgical

Paradigm Spine wins Coflex coverage from AmeriHealth Caritas

November 27, 2018 By Fink Densford

Paradigm Spine said today it won coverage for its Coflex interlaminar stabilization device intended to treat lumbar spinal stenosis from AmeriHealth Caritas. The Coflex interlaminar stabilization system is the New York-based company’s flagship device, and is designed for posterior lumbar preservation in patients with moderate to severe spinal stenosis. With the coverage, an additional 5.3 […]

Filed Under: Business/Financial News, Spine Tagged With: Paradigm Spine

RTI Surgical puts $300m on the table for Paradigm Spine

November 2, 2018 By Brad Perriello

RTI Surgical (NSDQ:RTIX) agreed to put $300 million on the table for Paradigm Spine and its Coflex lumbar stenosis device. The cash-and-stock deal calls for Alachua, Fla.-based RTI to pay $100 million in cash and more than 10.7 million shares of its own stock worth $50 million, with the $150 million balance pegged to unspecified milestones in […]

Filed Under: Featured, Mergers & Acquisitions, Orthopedics, Spine, Wall Street Beat Tagged With: Paradigm Spine, RTI Surgical

Paradigm Spine wins coverage for spinal stenosis implant

September 7, 2018 By Nancy Crotti

BlueCross BlueShield of South Carolina has extended coverage to Paradigm Spine’s Coflex interlaminar stabilization implant, the company announced today. Approved by the FDA in 2012, Coflex is a non-fusion, motion-preserving stabilization implant for the treatment of lumbar spinal stenosis (LSS). Used in conjunction with a decompression procedure or in lieu of a spinal fusion, Coflex is a single-piece, […]

Filed Under: Blog, Business/Financial News, Implants, Orthopedics, Spine Tagged With: FDA, Paradigm Spine

Paradigm Spine wins FDA PMA for Coflex disposable instrument set

May 2, 2018 By Fink Densford

Paradigm Spine said today it won FDA premarket approval for its Coflex Interlaminar stabilization disposable instrument kit, touting it as the first FDA PMA-cleared disposable spinal instrument set for a Class III spinal device. The Coflex interlaminar stabilization system is the New York-based company’s flagship device, and is designed for posterior lumbar preservation in patients […]

Filed Under: Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Compliance, Spine Tagged With: Paradigm Spine

Second Sight Medical taps Blake as CFO | Personnel Moves – March 27, 2018

March 27, 2018 By Fink Densford

Second Sight Medical (NSDQ:EYES) said last week it named John Blake as its new chief financial officer, succeeding Thomas Miller who has held the position since 2014. Before joining Second Sight Medical, Blake acted as finance senior VP at Tyr Pharma, and has held positions with Volcano Corp and BD Biosciences, the company said. Blake worked with […]

Filed Under: Business/Financial News Tagged With: acessahealth, Bayer, Boston Scientific, collagenmatrix, Dentsply Sirona, innovatusimaging, Integra LifeSciences, NovaBone, Nuvasive, Orthovita Inc., Paradigm Spine, Philips, Second Sight, Smith & Nephew, Trice Medical

Paradigm Spine lands $75 million in debt financing

February 21, 2014 By Chris Walker Leave a Comment

Paradigm Spine lands $75 million in debt financing

Paradigm Spine said it inked a $75 million credit agreement with PDL BioPharma.

Paradigm Spine, which makes spinal implants, said it will take the 1st $50 million in at closing, with another $25 million in milestone-based payments on the table.

Filed Under: Funding Roundup, News Well, Spine Tagged With: Paradigm Spine, PDL BioPharma

FDA approves Paradigm Spine’s cost-saving Coflex spinal stenosis treatment

October 18, 2012 By MassDevice staff Leave a Comment

Paradigm Spine won FDA approval for its Coflex spinal stenosis treatment system, the 1st such device to treat moderate to severe cases of spinal stenosis that may present with or without back pain.

Paradigm calls the Coflex device the "the 1st and only motion-preserving alternative to fusion for the treatment of moderate to severe spinal stenosis."

Filed Under: Food & Drug Administration (FDA), News Well, Pre-Market Approval (PMA), Spine Tagged With: Paradigm Spine

Vascular Nanotransfer Technologies taps new CEO

September 12, 2012 By MassDevice staff Leave a Comment

MassDevice.com Personnel Moves

 Vascular Nanotransfer Technologies taps new CEO

Filed Under: News Well Tagged With: EarlySense, InVivo Therapeutics, Lantheus Medical Imaging, Paradigm Spine, Personnel Moves, Torax Medical Inc., Vascular Nanotransfer Technologies

Ex-J&J CEO Weldon to walk with $143.5M in retirement | Personnel Moves

March 15, 2012 By MassDevice staff Leave a Comment

fired/hired

Outgoing Johnson & Johnson (NYSE:JNJ) CEO William Weldon will take home $143.5 million in retirement benefits when he walks in April.

The veteran J&J employee racked up more than $95 million in deferred compensation and $48.4 million in pension benefits over more than 40 years with the health care titan, according to an SEC filing.

Filed Under: News Well Tagged With: Aastron Biosciences, Johnson and Johnson, Medical Action Industries Inc., Nephros, Orthocon Inc., Paradigm Spine, Personnel Moves

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS